Respiratory Muscle Strength in Volleyball Players Suffered From COVID-19

Evaluation of Respiratory Muscle Strength and Pulmonary Functions in Volleyball Players Suffering From Covid-19

In literature, there is no data evaluating respiratory functions in volleyball players during Covid-19 pandemic. The aim of this study is to evaluate and compared pulmonary functions, respiratory muscle strength, body compositions and performance situations perceptions in female volleyball players with Covid-19 and non-Covid-19.

Study Overview

• Status: Completed
• Conditions: Covid19
• Intervention / Treatment: Other: Respiratory functions

• Study Type: Observational
• Enrollment (Actual): 42

Contacts and Locations

Study Locations

• Turkey
  • Çankaya
    • Ankara, Çankaya, Turkey, 06490
      • Gazi University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 15 years to 35 years (Child, Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

• Sampling Method: Probability Sample

Study Population

Female volleyball players

Description

Inclusion Criteria:

• having passed at least 30 days after the Polymerase Chain Reaction (PCR) test turned negative
• willing to participate in the study

Exclusion Criteria:

• having a history of chronic lung disease
• unwilling to participate in the study

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Covid-19 players; Female volleyball players with Covid-19	Other: Respiratory functions; Respiratory muscle strength, pulmonary functions and body composition were evaluated in volleyball players
non-Covid-19 players; Female volleyball players with non Covid-19	Other: Respiratory functions; Respiratory muscle strength, pulmonary functions and body composition were evaluated in volleyball players

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Respiratory muscle strength	Maximal inspiratory and expiratory muscle strength will be evaluated using mouth pressure device.	10 minute

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
FEV1	Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEV1 will be evaluated. The percentage of predicted value <70% will be expressed as abnormal.	5 minute
FVC	Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FVC will be evaluated. The percentage of predicted value <70% will be expressed as abnormal	5 minute
FEV1/FVC	Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEV1/FVC will be evaluated.	5 minute
PEF	Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. PEF will be evaluated. The percentage of predicted value <70% will be expressed as abnormal.	5 minute
FEF2575	Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEF2575 will be evaluated. The percentage of predicted value <50% will be expressed as abnormal.	5 minute
Fat mass	Fat mass will be evaluated using TANITA bioelectrical impedance analysis.	2 minute
Fat mass percent	Fat mass percent will be evaluated using TANITA bioelectrical impedance analysis.	2 minute
Fat-free mass	Fat-free mass will be evaluated using TANITA bioelectrical impedance analysis.	2 minute
Body mass index	Body mass index will be evaluated using TANITA bioelectrical impedance analysis.	2 minute
Predicted muscle mass	Predicted muscle mass will be evaluated using TANITA bioelectrical impedance analysis.	2 minute
Symptom severity perceptions	Symptom severity perceptions will be evaluated Numeric Rating Scale.The severity of symptoms perceptions related to Covid are scored 0-10 point. Higher scores indicate higher severity of symptoms.	1 minute
Performance situations perceptions	Performance situations perceptions will be evaluated Numeric Rating Scale. Performance situations perceptions of all players are also scored 0-10 point. Higher scores indicate greater performance.	1 minute

Collaborators and Investigators

• Sponsor: Gazi University

Publications and helpful links

General Publications

• Celik Z, Guzel NA, Kafa N, Kokturk N. Respiratory muscle strength in volleyball players suffered from COVID-19. Ir J Med Sci. 2022 Oct;191(5):1959-1965. doi: 10.1007/s11845-021-02849-z. Epub 2021 Nov 8.

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2021
• Primary Completion (Actual): March 26, 2021
• Study Completion (Actual): March 29, 2021

Study Registration Dates

• First Submitted: March 6, 2021
• First Submitted That Met QC Criteria: March 8, 2021
• First Posted (Actual): March 9, 2021

Study Record Updates

• Last Update Posted (Actual): April 1, 2021
• Last Update Submitted That Met QC Criteria: March 29, 2021
• Last Verified: March 1, 2021

More Information

Terms related to this study

• Keywords: pulmonary functions; respiratory muscles
• Additional Relevant MeSH Terms: Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; COVID-19
• Other Study ID Numbers: 2021-189

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No